Dr. Richardson has over 20 years of medicinal chemistry experience in integrated drug discovery, developing and implementing research strategies from lead generation to pre-IND candidate selection. He previously served as Discovery Program Leader at Cavion, Inc. (acquired by Jazz Pharmaceuticals), developing novel T-Type calcium channel inhibitors for neurological and oncology indications. He is the co-inventor of 15 patents and co-author of several publications in peer-reviewed journals, and has a broad knowledge base and experience in crafting new intellectual property to secure patent space. Dr. Richardson holds a PhD in Organic Chemistry from The Ohio State University.
